Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/17538174

J. Clin. Oncol. 2007 Jun 1 25 16 2281-7

Download in:

View as

General Info

PMID
17538174